ArticleFrontiers in medicine2026
Ethnic-specific ZJU index thresholds for hepatic steatosis and fibrosis in Chinese MASLD.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Zhejiang University (ZJU) index correlates with metabolic dysfunction-associated steatotic liver disease (MASLD) in Chinese cohorts, but its ethnic-specific thresholds for hepatic steatosis and fibrosis remain undefined. Methods: A cross-sectional study of 2,156 Chinese MASLD patients used vibration-controlled transient elastography (VCTE) and restricted cubic spline (RCS) modeling to analyze ZJU index associations with controlled attenuation parameter (CAP) and liver stiffness measurement (LSM). Results: The ZJU index independently correlated with both controlled attenuation parameter (CAP, β = 0.96 dB/m) and liver stiffness measurement (LSM, β = 0.042 kPa). Crucially, we identified ethnic-specific thresholds for Chinese populations (CAP: 46.38; LSM: 49.49) that are significantly lower than Western cohorts, characterized by rapid pre-threshold risk escalation and post-threshold plateaus. The strongest correlations appeared in males, the elderly, and non-obese individuals. Sensitivity analyses using multiple imputation showed materially consistent results. In addition, comparative analyses indicated that the ZJU index had generally comparable discriminatory performance compared to conventional indicators, outperforming several metabolic markers for fibrosis-related outcomes, although body mass index (BMI) and waist circumference showed slightly higher area under the curve (AUC) values in some fibrosis models. Conclusion: The ZJU index is a cost-effective tool for Chinese MASLD assessment, with ethnic-specific thresholds critical for accurate disease stratification in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.